- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05033860
The Influence of Education During Waiting Time of Vaccination on the Knowledge Towards COVID-19 Among Chinese Residents
September 1, 2021 updated by: Ningbo No. 1 Hospital
The Influence of Education During Waiting Time of Vaccination on the Knowledge Towards COVID-19 Among Chinese Residents: A Randomized Controlled Trial
Coronavirus disease 2019 (COVID-19) is a respiratory disease caused by a novel coronavirus, which has developed the global pandemic situation.
The promotion of vaccination is an effective strategy to control the epidemic.
A total of 19,5738,000 doses of COVID-19 vaccines have been reported in China until August 24th, 2021.
During widespread vaccination, the education in COVID-19 prevention and vaccination for residents are also crucial.
To figure out the influence of education during waiting time of vaccination, we have designed a randomized controlled trial and planned to distribute leaflets and questionnaires to the residents of Xidian (a town in Ninghai, Zhejiang).
This study is of great significance for the prevention of COVID-19 pandemic.
Study Overview
Status
Recruiting
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Anticipated)
312
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: Lei Xu, MD
- Phone Number: +86-13486659126
- Email: xulei22@163.com
Study Contact Backup
- Name: Siyi Yu
- Phone Number: +86-18857452628
- Email: yusysherry@gmail.com
Study Locations
-
-
Zhejiang
-
Ningbo, Zhejiang, China, 315010
- Recruiting
- Ningbo First Hospital
-
Contact:
- Lei Xu
- Phone Number: 13486659126
- Email: xulei22@163.com
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
Yes
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Age ≥18;
- Residents who are vaccinated with COVID-19 vaccines at Xidian Passenger Station from August 18th to September 20th, 2021;
- Able to understand the content of leaflets and questionnaires, and willing to participate in the study.
Exclusion Criteria:
- Residents who are unable to get vaccinated with COVID-19 vaccines;
- Unable to understand the content of leaflets and questionnaires, or unwilling to participate in the study;
- Unreturned or incomplete questionnaires.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Prevention
- Allocation: Randomized
- Interventional Model: Single Group Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Intervention group
Leaflets containing knowledge of COVID-19 and vaccination were distributed, and questionnaire surveys were conducted afterwards.
|
Leaflets containing knowledge of COVID-19 and vaccination were distributed, and participants are asked to read the leaflets.
|
No Intervention: Control group
Questionnaire surveys were conducted without leaflets distribution.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Scores of the questionnaire
Time Frame: 5-20 minutes
|
All the participants are asked to fulfill a questionnaire entitled "A survey on the public knowledge of COVID-19 and vaccination".
The total score of questionnaire is calculated (full mark is 24).
A higher score means a better knowledge of COVID-19 and vaccination.
|
5-20 minutes
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
August 18, 2021
Primary Completion (Anticipated)
September 20, 2021
Study Completion (Anticipated)
September 20, 2021
Study Registration Dates
First Submitted
August 30, 2021
First Submitted That Met QC Criteria
September 1, 2021
First Posted (Actual)
September 5, 2021
Study Record Updates
Last Update Posted (Actual)
September 5, 2021
Last Update Submitted That Met QC Criteria
September 1, 2021
Last Verified
August 1, 2021
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 2021-R087
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Covid19
-
Anavasi DiagnosticsNot yet recruiting
-
Ain Shams UniversityRecruiting
-
Israel Institute for Biological Research (IIBR)Completed
-
Colgate PalmoliveCompleted
-
Christian von BuchwaldCompleted
-
Luye Pharma Group Ltd.Shandong Boan Biotechnology Co., LtdActive, not recruiting
-
University of ZurichLabor Speiz; Swiss Armed Forces; Universitätsspital ZürichEnrolling by invitation
-
Alexandria UniversityCompleted
Clinical Trials on Read leaflets containing knowledge of COVID-19 and vaccination.
-
AstraZenecaCompleted
-
George Washington UniversityCompleted
-
Cairo UniversityRecruitingCOVID-19 | Rheumatic Diseases | Vaccination; InfectionEgypt
-
University of North Carolina, Chapel HillEnvironmental Protection Agency (EPA)Completed
-
University Medical Center GroningenRadboud University Medical Center; Maastricht University Medical Center; UMC... and other collaboratorsCompletedVaccine Response | Immunosuppression | COVID-19 Vaccines | Varicella Zoster VaccineNetherlands
-
Charles Drew University of Medicine and ScienceWithdrawnCoronavirusUnited States
-
Castilla-La Mancha Health ServiceCompleted
-
Charles Drew University of Medicine and ScienceEnrolling by invitationCoronavirus | Vaccine RefusalUnited States
-
Sarang K. Yoon, DO, MOHNovavax; WestatRecruitingCOVID-19 | SARS CoV 2 Infection | Vaccine-Preventable Diseases | Upper Respiratory Tract Infection | Upper Respiratory DiseaseUnited States
-
Fondazione Policlinico Universitario Agostino Gemelli...CompletedPregnant Women | Vaccination Hesitancy | COVID 19 VaccineItaly